v3.26.3
TRADE RECEIVABLES AND OTHER
9 Months Ended
Sep. 30, 2026
Receivables [Abstract]  
TRADE RECEIVABLES AND OTHER NOTE 8 - TRADE RECEIVABLES AND OTHER
At September 30,
2026
At December 31,
2025
(in millions of U.S. dollars)
Current
Current
Trade receivables - gross
869
614
Allowance for credit losses
(4)
(3)
Total trade receivables - net
865
611
Total other receivables
138
112
Total trade receivables and other
1,003
723
Factoring arrangements
The Group has entered into several accounts receivable factoring programs with selected financial institutions for certain
receivables of the Group. The programs are accounted for as sales of the receivables and had combined limits of approximately
$711 million and $729 million at September 30, 2026 and December 31, 2025, respectively.
Proceeds on receivables sold under our ongoing factoring programs were $1,103 million and $968 million for the three
months ended September 30, 2026 and 2025, respectively. Proceeds on receivables sold under our ongoing factoring programs
were $3,092 million and $2,720 million for the nine months ended September 30, 2026 and 2025, respectively. At September
30, 2026 and December 31, 2025, the total amount of receivables derecognized under the Group’s factoring arrangements was
$417 million and $430 million, respectively.
Starting in fiscal year 2025, the proceeds from the sale of accounts receivables consisted of only cash. Prior to January 1,
2025, the proceeds from the sale of certain of these receivables was comprised of a combination of cash and deferred purchase
price receivable. The deferred purchase price receivable was ultimately realized by the Group following the collection by the
financial institutions of the underlying receivables sold. For the nine months ended September 30, 2025, the beginning deferred
purchase price balance was $2 million, of which $2 million was fully collected in cash. This resulted in an ending deferred
purchase price receivable balance of $0 million for the nine months ended September 30, 2025, recorded in Fair value of
derivative instruments and other financial assets in the Consolidated Balance Sheets.
The Group has recorded 6 million and 5 million of expenses related to its factoring programs in the three months ended
September 30, 2026 and 2025, respectively. The Group has recorded $15 million and $16 million of expenses related to its
factoring programs in the nine months ended September 30, 2026 and 2025, respectively. These amounts are presented in Other
gains and losses – net in its Interim Consolidated Income Statement.